[EN] COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS<br/>[FR] COMPOSÉS POUR ACTIVER DES LYMPHOCYTES T TUEURS NATURELS INVARIANTS ET MÉTHODES D'UTILISATION DANS L'ÉLIMINATION DE CELLULES SÉNESCENTES INFLAMMATOIRES
申请人:DECIDUOUS THERAPEUTICS
公开号:WO2022187141A1
公开(公告)日:2022-09-09
Compounds for activating invariant natural killer T cells (iNKT) cells are provided. Compounds according to certain embodiments activate iNKT cells and induce an increase in the production of one or more cytokines, such as IFNγ, IL-2, IL-4, IL-6 and TNFα. In some embodiments, activated iNKT cells are used to selectively reduce the presence of or eliminate inflammatory senescent cells, such as senescent cells having an inflammatory secretome (SASP). Methods for activating iNKT cells by contacting an iNKT cell with an amount of the subject compounds and selectively reducing the presence of or eliminating senescent cells with activated iNKT cells are also described. Compositions for practicing the subject methods are also described.
本发明提供了用于激活不变自然杀伤T细胞(iNKT)细胞的化合物。根据某些实施例,这些化合物可以激活iNKT细胞并诱导产生一个或多个细胞因子的增加,例如IFNγ、IL-2、IL-4、IL-6和TNFα。在某些实施例中,激活的iNKT细胞被用于选择性地减少或消除炎症衰老细胞,例如具有炎症分泌物(SASP)的衰老细胞。本发明还描述了通过将iNKT细胞与所述化合物的适量接触来激活iNKT细胞并通过激活的iNKT细胞选择性地减少或消除衰老细胞的方法。还描述了用于实施所述方法的组合物。